197 related articles for article (PubMed ID: 18792821)
1. [In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit].
López-Fabal F; Culebras E; Bonilla I; Gómez M; Picazo JJ
Rev Esp Quimioter; 2008 Sep; 21(3):189-93. PubMed ID: 18792821
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
3. Combinations of antimicrobial agents. I. The in vitro sensitivity of 100 strains of Pseudomonas aeruginosa to polymyxin B, colistin, carbenicillin, gentamicin and doxycycline and to various combinations of these antibiotics.
Kuipers JS
Arch Chir Neerl; 1975; 27(4):257-70. PubMed ID: 174496
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Güzel CB; Gerçeker AA
Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
7. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit.
Ratnam I; Franklin C; Spelman DW
Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
[TBL] [Abstract][Full Text] [Related]
10. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.
Landman D; Bratu S; Alam M; Quale J
J Antimicrob Chemother; 2005 Jun; 55(6):954-7. PubMed ID: 15883174
[TBL] [Abstract][Full Text] [Related]
11. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
[TBL] [Abstract][Full Text] [Related]
12. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
[TBL] [Abstract][Full Text] [Related]
13. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
[TBL] [Abstract][Full Text] [Related]
16. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
[TBL] [Abstract][Full Text] [Related]
17. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
Obritsch MD; Fish DN; MacLaren R; Jung R
Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
[TBL] [Abstract][Full Text] [Related]
18. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.
Tascini C; Gemignani G; Ferranti S; Tagliaferri E; Leonildi A; Lucarini A; Menichetti F
J Chemother; 2004 Jun; 16(3):282-7. PubMed ID: 15330326
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
Mitsugui CS; Tognim MC; Cardoso CL; Carrara-Marroni FE; Botelho Garcia L
Int J Antimicrob Agents; 2011 Nov; 38(5):447-50. PubMed ID: 21872449
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.
Erlandsson M; Gill H; Nordlinder D; Giske CG; Jonas D; Nilsson LE; Walther S; Hanberger H
Scand J Infect Dis; 2008; 40(6-7):487-94. PubMed ID: 18584536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
